Currently, an important part of the anti-tumor treatment strategy of NSCLC, especially LUAD, is treatment with a variety of anti-tumor drugs—mainly various cytotoxic chemotherapeutics and molecular targeted drugs as protein kinase inhibitors or the combined use of these drugs 57,58. Here, WEE1 is linked to non-small cell lung carcinoma.